Case series of the first three severe COVID-19 patients treated with the secretome of hypoxia-mesenchymal stem cells in Indonesia

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the outbreak of coronavirus disease 2019 (COVID-19), which has been rapidly spreading. Several guideline therapies have been proposed as a possible treatment for SARS-CoV-2, however, these therapies are not sufficient to...

Descripción completa

Detalles Bibliográficos
Autores principales: Putra, Agung, Widyatmoko, Agus, Ibrahim, Sugeng, Amansyah, Fajar, Amansyah, Farid, Berlian, Mukti Arja, Retnaningsih, Retnaningsih, Pasongka, Zenitalia, Sari, Flora Eka, Rachmad, Basuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2021
Materias:
Clinical Practice Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8927740/
https://www.ncbi.nlm.nih.gov/pubmed/35350705
http://dx.doi.org/10.12688/f1000research.51191.3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8927740/
https://www.ncbi.nlm.nih.gov/pubmed/35350705
http://dx.doi.org/10.12688/f1000research.51191.3

Ejemplares similares